Glycoprotein IIb/IIIa antagonists

被引：13
|
作者：
Wityak, J
Sielecki, TM
机构：
[1] DuPont Merck Pharmaceutical Company, Chemical/Physical Sciences Dept., Wilmington, DE 19880-0500
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 1996年 / 6卷 / 11期
关键词：
glycoprotein IIb/lIIa GPIIb/IIIa; integrin; platelet aggregation inhibitor;
D O I：
10.1517/13543776.6.11.1175
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Glycoprotein IIb/IIIa (GPlIb/IIIa) antagonists have been shown to be effective in reducing the rate of ischaemic complications due to pathophysiological conditions such as atherosclerosis or coronary intervention. This review will cover all patenting activity in this now mature field of research up to and including August 1996, and will focus on the more significant patents and patent applications.
引用
收藏
页码：1175 / 1194
页数：20
相关论文
共 50 条
  • [21] Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists
    Heeschen, C
    Hamm, CW
    LANCET, 2000, 355 (9201): : 330 - 331
  • [22] Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina
    Steinhubl, SR
    Moliterno, DJ
    HEART AND VESSELS, 1997, : 148 - 155
  • [23] Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists
    Huxtable, LM
    Tafreshi, MJ
    Rakkar, ANS
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03): : 426 - 429
  • [24] Platelet glycoprotein IIb/IIIa antagonists in ischemic cerebrovascular disease
    Leclerc, JR
    Mascelli, MA
    Weisman, HF
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 575 - 579
  • [25] Long-term administration of glycoprotein IIb/IIIa antagonists
    Quinn, M
    Fitzgerald, DJ
    AMERICAN HEART JOURNAL, 1998, 135 (05) : S113 - S118
  • [26] Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists
    Araujo, R
    Agustí, A
    MEDICINA CLINICA, 2000, 115 (11): : 435 - 437
  • [27] Oral glycoprotein IIb/IIIa antagonists in coronary artery disease
    Chew D.P.
    Bhatt D.L.
    Current Cardiology Reports, 2001, 3 (1) : 63 - 71
  • [28] The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics
    Kurt Huber
    Journal of Thrombosis and Thrombolysis, 2003, 15 : 99 - 103
  • [29] Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists
    Wityak, J
    Sielecki, TM
    Pinto, DJ
    Emmett, G
    Sze, JY
    Liu, J
    Tobin, AE
    Wang, SA
    Jiang, B
    Ma, P
    Mousa, SA
    Wexler, RR
    Olson, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (01) : 50 - 60
  • [30] Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases
    Chong, PH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (22) : 2363 - 2386
12345